Literature DB >> 8453259

A preparation from bovine colostrum in the treatment of HIV-positive patients with chronic diarrhea.

A Plettenberg1, A Stoehr, H J Stellbrink, H Albrecht, W Meigel.   

Abstract

In a prospective, open, uncontrolled study 25 patients infected with the human immunodeficiency virus with chronic refractory diarrhea and either confirmed cryptosporidiosis (n = 7) or absence of demonstrable pathogenic organisms (n = 18) were treated with a daily oral dose of 10 g of an immunoglobulin preparation from bovine colostrum over a period of 10 days. Among the 7 patients with cryptosporidiosis, this treatment led to complete remission in 3 and partial remission in 2. Among the 18 patients with diarrhea and negative stool culture, complete remission of diarrhea was obtained in 7 and partial remission in 4. In the remaining 2 patients with cryptosporidiosis and the 7 patients with diarrhea but no demonstrable pathogens treatment produced no significant improvement of the diarrhea. Subsequent doubling of the Lactobin dose (2 x 10 g daily) in 8 of the nonresponders led to complete remission in one case and at least partial remission in a further 4 patients. Treatment of refractory diarrhea with 10 g immunoglobulins from bovine colostrum per day constitutes an important therapeutic approach and led to complete (40%) or partial (24%) remission of diarrhea in 64% of the patients described here.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453259     DOI: 10.1007/bf00210962

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  21 in total

1.  Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum.

Authors:  S Tzipori; D Roberton; C Chapman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-15

2.  Antibodies from colostrum in oral immunotherapy.

Authors:  W Stephan; H Dichtelmüller; R Lissner
Journal:  J Clin Chem Clin Biochem       Date:  1990-01

3.  Inhibition of enteropathogenic bacteria by human milk whey in vitro.

Authors:  S A Dolan; M Boesman-Finkelstein; R A Finkelstein
Journal:  Pediatr Infect Dis J       Date:  1989-07       Impact factor: 2.129

4.  Secretory IgA, a major immunoglobulin in most bovine external secretions.

Authors:  J P Mach; J J Pahud
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

5.  Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients.

Authors:  J Nord; P Ma; D DiJohn; S Tzipori; C O Tacket
Journal:  AIDS       Date:  1990-06       Impact factor: 4.177

6.  Opsonic activity and O-agglutinins against Escherichia coli in bovine colostrum.

Authors:  A Seto; T Okabe; N Sasaki; Y Ito
Journal:  Am J Vet Res       Date:  1976-06       Impact factor: 1.156

7.  Prevention of rotavirus infection by oral administration of cow colostrum containing antihumanrotavirus antibody.

Authors:  T Ebina; A Sato; K Umezu; N Ishida; S Ohyama; A Oizumi; K Aikawa; S Katagiri; N Katsushima; A Imai
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

8.  Intestinal infections in patients with AIDS.

Authors:  M K Sachs; G M Dickinson
Journal:  Postgrad Med       Date:  1989-03       Impact factor: 3.840

9.  Immunoglobulins in bovine mammary secretions. Quantitative changes in early lactation and absorption by the neonatal calf.

Authors:  P Porter
Journal:  Immunology       Date:  1972-08       Impact factor: 7.397

10.  Efficacy of orally administered immune serum globulin against type III group B streptococcal colonization and systemic disease in an infant rat model.

Authors:  K S Kim; K Dunn; S A McGeary; E R Stiehm
Journal:  Pediatr Res       Date:  1984-12       Impact factor: 3.756

View more
  14 in total

Review 1.  Passive immunity against human pathogens using bovine antibodies.

Authors:  C Weiner; Q Pan; M Hurtig; T Borén; E Bostwick; L Hammarström
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

2.  Effect of bovine colostrum-based food supplement in the treatment of HIV-associated diarrhea in Northern Uganda: a randomized controlled trial.

Authors:  F O Kaducu; S A Okia; G Upenytho; L Elfstrand; C-H Florén
Journal:  Indian J Gastroenterol       Date:  2011-12-13

3.  Comments regarding the claimed effectiveness of bovine colostrum - A reply.

Authors:  C Taillon
Journal:  Can Vet J       Date:  2000-06       Impact factor: 1.008

Review 4.  Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection.

Authors:  Denise C Hsu; Irini Sereti
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

5.  Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products.

Authors:  W B Strong; J Gut; R G Nelson
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  In vitro inhibition of Cryptosporidium parvum infection by human monoclonal antibodies.

Authors:  B C Elliot; A V Wisnewski; J Johnson; D Fenwick-Smith; P Wiest; D Hamer; T Kresina; T P Flanigan
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

7.  Persistent immune activation in chronic HIV infection: do any interventions work?

Authors:  Reena Rajasuriar; Gabriela Khoury; Adeeba Kamarulzaman; Martyn A French; Paul U Cameron; Sharon R Lewin
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

Review 8.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

9.  Management of chronic diarrhea in HIV-infected patients: current treatment options, challenges and future directions.

Authors:  Lidia Elfstrand; Claes-Henrik Florén
Journal:  HIV AIDS (Auckl)       Date:  2010-11-10

10.  Gut mucosa in HIV infection: "immune milk" solution.

Authors:  Shawn J Green
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.